In our in silico analyses of the TCGA-GBM cohort, expression of the well-known embryonic stem cell markers NANOG and GLI1 [28] was significantly enhanced in the FGFR4high subgroup (mRNA log2 fold change (FC): 0.78 and 2.42, respectively). This evidence concerns the gene GLI1 and glioblastoma.